Skip to main content
. 2020 Dec 24;27(1):1073274820983013. doi: 10.1177/1073274820983013

Figure 2.

Figure 2.

Schematic representation of signaling pathways in biliary tract cancer, with a particular focus on the mitogen-activated protein kinase (MAPK) / extracellular signal-regulated kinase (ERK), or RAS/RAF/MEK/ERK pathway, with BRAF and MEK inhibitors.